Patent ID: 8580945
Filing Date: 2013-11-12
Classification: C12Q

Abstract:
1. An oligonucleotide complementary to a target polynucleotide, wherein the oligonucleotide is selected from the group consisting of: SEQ ID No: 9, SEQ ID No: 10, SEQ ID No: 11, SEQ ID No: 12, SEQ ID No: 13, SEQ ID No: 14, SEQ ID No: 15, SEQ ID No: 16, SEQ ID No: 17, or SEQ ID No: 18, wherein the nucleotide at the 3′ end of SEQ ID Nos. 9 and 10 is an LNA unit, the nucleotide one position away from the 3′ end of SEQ ID Nos. 11 and 12 is an LNA unit, the nucleotide two positions away from the 3′ end of SEQ ID Nos. 13 and 14 is an LNA unit, the nucleotide three positions away from the 3′ end of SEQ ID Nos. 15 and 16 is an LNA unit, and the nucleotide four positions away from the 3′ end of SEQ ID Nos. 17 and 18 is an LNA unit.